Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy

被引:14
作者
Strouse, Christopher [1 ]
Mangalam, Ashutosh [2 ]
Zhang, Jun [1 ]
机构
[1] Holden Comprehens Canc Ctr, Dept Internal Med, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA USA
[2] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA
关键词
Microbiome; cancer immunotherapy; ANTIBIOTIC USE;
D O I
10.1080/19490976.2018.1511665
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The influence of the composition of the human microbiome on the efficacy of cancer directed immunotherapies, such as antibodies directed against the programmed cell death 1 protein (PD-1) or its ligand (PD-L1), has garnered increasing attention as the role of immunotherapies in the care of cancer has grown. Dysbiosis (altered microbiota) has recently been reported to adversely affect the efficacy of cancer directed immunotherapies, and correction of this dysbiosis has the potential to improve the efficacy of these treatments. However, the exact mechanisms underlying this relationship remains unknown. Current methods for characterizing the microbiome likely capture only a small portion of the highly complex interaction between the microbiome and the immune system. Here we discuss the recent reports of the influence of dysbiosis on cancer immunotherapy, methods to more fully characterize the interaction between the microbiome and the immune system, and methods of modulating the immune system to improve the efficacy of cancer immunotherapy.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 17 条
  • [1] Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
    Gopalakrishnan, V.
    Spencer, C. N.
    Nezi, L.
    Reuben, A.
    Andrews, M. C.
    Karpinets, T. V.
    Prieto, P. A.
    Vicente, D.
    Hoffman, K.
    Wei, S. C.
    Cogdill, A. P.
    Zhao, L.
    Hudgens, C. W.
    Hutchinson, D. S.
    Manzo, T.
    de Macedo, M. Petaccia
    Cotechini, T.
    Kumar, T.
    Chen, W. S.
    Reddy, S. M.
    Sloane, R. Szczepaniak
    Galloway-Pena, J.
    Jiang, H.
    Chen, P. L.
    Shpall, E. J.
    Rezvani, K.
    Alousi, A. M.
    Chemaly, R. F.
    Shelburne, S.
    Vence, L. M.
    Okhuysen, P. C.
    Jensen, V. B.
    Swennes, A. G.
    McAllister, F.
    Sanchez, E. Marcelo Riquelme
    Zhang, Y.
    Le Chatelier, E.
    Zitvogel, L.
    Pons, N.
    Austin-Breneman, J. L.
    Haydu, L. E.
    Burton, E. M.
    Gardner, J. M.
    Sirmans, E.
    Hu, J.
    Lazar, A. J.
    Tsujikawa, T.
    Diab, A.
    Tawbi, H.
    Glitza, I. C.
    [J]. SCIENCE, 2018, 359 (6371) : 97 - 103
  • [2] Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer
    Hayes, Richard B.
    Ahn, Jiyoung
    Fan, Xiaozhou
    Peters, Brandilyn A.
    Ma, Yingfei
    Yang, Liying
    Agalliu, Ilir
    Burk, Robert D.
    Ganly, Ian
    Purdue, Mark P.
    Freedman, Neal D.
    Gapstur, Susan M.
    Pei, Zhiheng
    [J]. JAMA ONCOLOGY, 2018, 4 (03) : 358 - 365
  • [3] Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis
    Hughes, Elizabeth R.
    Winter, Maria G.
    Duerkop, Breck A.
    Spiga, Luisella
    de Carvalho, Tatiane Furtado
    Zhu, Wenhan
    Gillis, Caroline C.
    Buttner, Lisa
    Smoot, Madeline P.
    Behrendt, Cassie L.
    Cherry, Sara
    Santos, Renato L.
    Hooper, Lora V.
    Winter, Sebastian E.
    [J]. CELL HOST & MICROBE, 2017, 21 (02) : 208 - 219
  • [4] Structure, function and diversity of the healthy human microbiome
    Huttenhower, Curtis
    Gevers, Dirk
    Knight, Rob
    Abubucker, Sahar
    Badger, Jonathan H.
    Chinwalla, Asif T.
    Creasy, Heather H.
    Earl, Ashlee M.
    FitzGerald, Michael G.
    Fulton, Robert S.
    Giglio, Michelle G.
    Hallsworth-Pepin, Kymberlie
    Lobos, Elizabeth A.
    Madupu, Ramana
    Magrini, Vincent
    Martin, John C.
    Mitreva, Makedonka
    Muzny, Donna M.
    Sodergren, Erica J.
    Versalovic, James
    Wollam, Aye M.
    Worley, Kim C.
    Wortman, Jennifer R.
    Young, Sarah K.
    Zeng, Qiandong
    Aagaard, Kjersti M.
    Abolude, Olukemi O.
    Allen-Vercoe, Emma
    Alm, Eric J.
    Alvarado, Lucia
    Andersen, Gary L.
    Anderson, Scott
    Appelbaum, Elizabeth
    Arachchi, Harindra M.
    Armitage, Gary
    Arze, Cesar A.
    Ayvaz, Tulin
    Baker, Carl C.
    Begg, Lisa
    Belachew, Tsegahiwot
    Bhonagiri, Veena
    Bihan, Monika
    Blaser, Martin J.
    Bloom, Toby
    Bonazzi, Vivien
    Brooks, J. Paul
    Buck, Gregory A.
    Buhay, Christian J.
    Busam, Dana A.
    Campbell, Joseph L.
    [J]. NATURE, 2012, 486 (7402) : 207 - 214
  • [5] Antibiotic Use Does Not Appear to Influence Response to Nivolumab
    Kaderbhai, Coureche
    Richard, Corentin
    Fumet, Jean David
    Aarnink, Anne
    Foucher, Pascal
    Coudert, Bruno
    Favier, Laure
    Lagrange, Aurelie
    Limagne, Emeric
    Boidot, Romain
    Ghiringhelli, Francois
    [J]. ANTICANCER RESEARCH, 2017, 37 (06) : 3195 - 3200
  • [6] Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects
    Liu, Hai-Xia
    Tao, Li-Li
    Zhang, Jing
    Zhu, Ying-Gang
    Zheng, Yu
    Liu, Dong
    Zhou, Min
    Ke, Hui
    Shi, Meng-Meng
    Qu, Jie-Ming
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (04) : 769 - 778
  • [7] Antibiotics and the gut microbiota
    Modi, Sheetal R.
    Collins, James J.
    Relman, David A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) : 4212 - 4218
  • [8] Immune Checkpoint Blockade in Cancer Therapy
    Postow, Michael A.
    Callahan, Margaret K.
    Wolchok, Jedd D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1974 - U161
  • [9] Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
    Routy, Bertrand
    Le Chatelier, Emmanuelle
    Derosa, Lisa
    Duong, Connie P. M.
    Alou, Maryam Tidjani
    Daillere, Romain
    Fluckiger, Aurelie
    Messaoudene, Meriem
    Rauber, Conrad
    Roberti, Maria P.
    Fidelle, Marine
    Flament, Caroline
    Poirier-Colame, Vichnou
    Opolon, Paule
    Klein, Christophe
    Iribarren, Kristina
    Mondragon, Laura
    Jacquelot, Nicolas
    Qu, Bo
    Ferrere, Gladys
    Clemenson, Celine
    Mezquita, Laura
    Masip, Jordi Remon
    Naltet, Charles
    Brosseau, Solenn
    Kaderbhai, Coureche
    Richard, Corentin
    Rizvi, Hira
    Levenez, Florence
    Galleron, Nathalie
    Quinquis, Benoit
    Pons, Nicolas
    Ryffel, Bernhard
    Minard-Colin, Veronique
    Gonin, Patrick
    Soria, Jean-Charles
    Deutsch, Eric
    Loriot, Yohann
    Ghiringhelli, Francois
    Zalcman, Gerard
    Goldwasser, Francois
    Escudier, Bernard
    Hellmann, Matthew D.
    Eggermont, Alexander
    Raoult, Didier
    Albiges, Laurence
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. SCIENCE, 2018, 359 (6371) : 91 - +
  • [10] Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
    Selby, Warwick
    Pavli, Paul
    Crotty, Brendan
    Florin, Tim
    Radford-Smith, Graham
    Gibson, Peter
    Mitchell, Brent
    Connell, William
    Read, Robert
    Merrett, Michael
    Ee, Hooi
    Hetzel, David
    [J]. GASTROENTEROLOGY, 2007, 132 (07) : 2313 - 2319